$2.44T
Total marketcap
$134.95B
Total volume
BTC 49.88%     ETH 16.82%
Dominance

ImmunoGen IMGN Stock

31.23 USD {{ price }} 0.000000% {{change_pct}}%
Exchange
NasdaqGS
Market Cap
8.72B USD
LOW - HIGH [24H]
0.0000 - 0.0000 USD
VOLUME [24H]
0 USD
{{ volume }}
P/E Ratio
0
Earnings per share
0 USD

ImmunoGen Price Chart

ImmunoGen IMGN Financial and Trading Overview

ImmunoGen stock price 31.23 USD
Previous Close 17.72 USD
Open 18.55 USD
Bid 0 USD x 1300
Ask 0 USD x 900
Day's Range 18.03 - 18.93 USD
52 Week Range 3.35 - 18.93 USD
Volume 8.89M USD
Avg. Volume 7.19M USD
Market Cap 4.79B USD
Beta (5Y Monthly) 0.891197
PE Ratio (TTM) N/A
EPS (TTM) 0 USD
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est 17.67 USD

IMGN Valuation Measures

Enterprise Value 3.82B USD
Trailing P/E N/A
Forward P/E -103.888885
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 39.699097
Price/Book (mrq) 34.693882
Enterprise Value/Revenue 31.674
Enterprise Value/EBITDA -16.001

Trading Information

ImmunoGen Stock Price History

Beta (5Y Monthly) 0.891197
52-Week Change 404.04%
S&P500 52-Week Change 20.43%
52 Week High 18.93 USD
52 Week Low 3.35 USD
50-Day Moving Average 10.67 USD
200-Day Moving Average 6.32 USD

IMGN Share Statistics

Avg. Volume (3 month) 7.19M USD
Avg. Daily Volume (10-Days) 7.03M USD
Shares Outstanding 255.97M
Float 190.46M
Short Ratio 1.4
% Held by Insiders 0.36%
% Held by Institutions 90.67%
Shares Short 17.8M
Short % of Float 6.96%
Short % of Shares Outstanding 6.95%

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2022
Most Recent Quarter (mrq) March 31, 2023
Next Fiscal Year End December 31, 2023

Profitability

Profit Margin -198.88%
Operating Margin (ttm) -199.40%
Gross Margin -83.71%
EBITDA Margin -197.95%

Management Effectiveness

Return on Assets (ttm) -39.029%
Return on Equity (ttm) -111.95%

Income Statement

Revenue (ttm) 120.57M USD
Revenue Per Share (ttm) 0.47 USD
Quarterly Revenue Growth (yoy) 31.00%
Gross Profit (ttm) -104764000 USD
EBITDA -238676000 USD
Net Income Avi to Common (ttm) -239798000 USD
Diluted EPS (ttm) -0.93
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 201.25M USD
Total Cash Per Share (mrq) 0.89 USD
Total Debt (mrq) 14.26M USD
Total Debt/Equity (mrq) 11.7 USD
Current Ratio (mrq) 2.4
Book Value Per Share (mrq) 0.539

Cash Flow Statement

Operating Cash Flow (ttm) -262119008 USD
Levered Free Cash Flow (ttm) -130357872 USD

Profile of ImmunoGen

Country United States
State MA
City Waltham
Address 830 Winter Street
ZIP 02451-1477
Phone 781 895 0600
Website https://www.immunogen.com
Industry Biotechnology
Sector(s) Healthcare
Full Time Employees 277

ImmunoGen, Inc., a commercial-stage biotechnology company, focuses on developing and commercializing the antibody-drug conjugates (ADCs) for cancer patients. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), for the treatment of platinum-resistant ovarian cancer; and a cell-surface protein expressed in various epithelial tumors, including ovarian, endometrial, and non-small-cell lung cancers, as well as Pivekimab sunirine, a CD123-targeting ADC that is in Phase II clinical trial for treating acute myeloid leukemia and blastic plasmacytoid dendritic cell neoplasm. Its preclinical programs include IMGC936, an ADC in co-development with MacroGenics, Inc.; and IMGN151, an anti-FRa product candidate. The company has collaborations with Roche; Amgen/Oxford BioTherapeutics; Bayer HealthCare AG; Eli Lilly and Company; Novartis Institutes for BioMedical Research, Inc.; CytomX Therapeutics, Inc.; Fusion Pharmaceuticals Inc.; Debiopharm International SA; and MacroGenics, Inc. ImmunoGen, Inc. was founded in 1980 and is headquartered in Waltham, Massachusetts.

Q&A For ImmunoGen Stock

What is a current IMGN stock price?

ImmunoGen IMGN stock price today per share is 31.23 USD.

How to purchase ImmunoGen stock?

You can buy IMGN shares on the NasdaqGS exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for ImmunoGen?

The stock symbol or ticker of ImmunoGen is IMGN.

Which industry does the ImmunoGen company belong to?

The ImmunoGen industry is Biotechnology.

How many shares does ImmunoGen have in circulation?

The max supply of ImmunoGen shares is 279.35M.

What is ImmunoGen Price to Earnings Ratio (PE Ratio)?

ImmunoGen PE Ratio is 0.00000000 now.

What was ImmunoGen earnings per share over the trailing 12 months (TTM)?

ImmunoGen EPS is 0 USD over the trailing 12 months.

Which sector does the ImmunoGen company belong to?

The ImmunoGen sector is Healthcare.

ImmunoGen IMGN included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
{{ item.name }} {{ item.symbol }} {{ item.price }} {{ item.price_usd }}
{{ item.change_pct }}
{{ item.volume }} {{ item.volume_usd }} {{ item.low }} {{ item.low_usd }} {{ item.high }} {{ item.high_usd }} {{ item.components_count }} {{ item.volume }} {{ item.volume_usd }}
NASDAQ Composite IXIC 16274.94 USD
+1.14
4.86B USD 16096.6 USD 16302.24 USD 4.86B USD
NASDAQ Composite Total Return I XCMP 19765.62 USD
+1.14
19549.03 USD 19798.77 USD
Stlmt ID NASDAQ Biotechnology NBX 4604.4 USD
-2.98
5292.16 USD 5437.06 USD
NASDAQ Biotechnology Total Retu XNBI 4840.8 USD
+1.96
4764.64 USD 4865.67 USD
NASDAQ Global Select Market Com NQGS 7911.05 USD
+1.14
7824.46 USD 7924.31 USD
NASDAQ Biotechnology NBI 4515.22 USD
+1.96
4444.18 USD 4538.42 USD
NASDAQ HealthCare IXHC 1018.62 USD
+2.02
1001.06 USD 1021.85 USD